News and Publications
February 24, 2020
Funding development of 5-minute point-of-care molecular diagnostics . Prominex, Inc., a molecular diagnostic company focused on point-of-care infectious disease testing, today announces completion of its Series B-1 financing, raising $8 million from Casdin Capital LLC.
May 31, 2019
Funding development of 5-minute point-of-care molecular diagnostics . Prominex, Inc., a molecular diagnostic company focused on point-of-care infectious disease testing, today announces completion of its Series B financing, raising $6 million from Casdin Capital LLC and Paul Thomas, its founding CEO.
September 26, 2018
NEW YORK (GenomeWeb) – With novel amplification and detection technology, startup Prominex promises fully-automated multiplex molecular point-of-care testing that can provide results in five minutes.
September 13, 2018
Funding development of 5-minute point-of-care molecular diagnostics . Prominex, Inc., a molecular diagnostic company focused on point-of-care infectious disease testing, today announces completion of its Series A-1 financing, raising $4 million from Casdin Capital LLC and Paul Thomas, its founding CEO.
January 5, 2018
Funding development of 5-minute point-of-care molecular diagnostics . Prominex, Inc., a molecular diagnostic company focused on point-of-care infectious disease testing, today announces completion of its Series A financing, raising $1.2 million from Casdin Capital LLC and Paul Thomas, its founding CEO.
Company Presentation
Click HERE to download Prominex Company Overview